|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Breast Cancer | |||||
| Cervical Cancer | |||||
| Head and Neck Cancer | |||||
| Prostate Cancer | |||||
| Sarcoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| Head and Neck Neoplasms | |||||
| Prostatic Neoplasms | |||||
| Uterine Cervical Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Genital Diseases, Female | |||||
| Genital Diseases, Male | |||||
| Genital Neoplasms, Female | |||||
| Genital Neoplasms, Male | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| Prostatic Diseases | |||||
| Skin Diseases | |||||
| Urogenital Neoplasms | |||||
| Uterine Cervical Diseases | |||||
| Uterine Diseases | |||||
| Uterine Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| EF5 | |||||
| biopsy | |||||
| flow cytometry | |||||
| fluorescent antibody technique | |||||
| 5 | Sponsors listed in this trial | ||||
| Princess Margaret Hospital, Canada | |||||
| National Cancer Institute (NCI) | |||||